Considering the tumor heterogeneity of the two clusters, we identified six prognostic genes (PIM2, PET117, SMARCA5, TAF9, ABCB10, MKP1) among the m6A-hypoxia genes and developed a scoring system to evaluate m6A modification patterns and hypoxia status. This evidence concerns the gene SMARCA5 and neoplasm.